Element Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Element Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-104	Closed	-$7.59K	–	268
2023 Q3	$7.59K	Hold	104	–	–	0.01%	220
2023 Q2	$8.65K	Hold	104	–	–	0.01%	210
2023 Q1	$7.93K	Buy	+104	New	+$8.63K	0.01%	189
2022 Q4	–	Sell	-104	Closed	-$8K	–	220
2022 Q3	$8K	Buy	104 +79	+316%	+$6.66K	0.01%	168
2022 Q2	$2K	Hold	25	–	–	﹤0.01%	186
2022 Q1	$2K	Buy	25 +7	+39%	+$646	﹤0.01%	201
2021 Q4	$2K	Buy	18 +2	+13%	+$241	﹤0.01%	187
2021 Q3	$2K	Buy	16 +4	+33%	+$515	﹤0.01%	178
2021 Q2	$2K	Buy	+12	New	+$1.58K	﹤0.01%	171

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

CHP

Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Element Wealth's XBI Position: Q4 2023 in Review

Element Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 104 shares — an estimated $7.59K sold.

Element Wealth first reported a position in XBI in Q2 2021 and held it in 9 quarters. The position peaked at $8.65K in Q2 2023. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Element Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
Element Wealth sold 104 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $7.59K.
Element Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 9 quarters.
Element Wealth's State Street SPDR S&P Biotech ETF position peaked at $8.65K in Q2 2023.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Element Wealth's 13F filing for Q4 2023, filed 1 Feb 2024.